Cytokine circuitries as determinants of response, resistance, and toxicity across cancer immunotherapy platforms
{{output}}
Cancer immunotherapy has substantially improved the management of solid tumors and hematologic malignancies; however, durable clinical benefit remains limited by primary and acquired therapeutic resistance, immune-related toxicities, and considerable interpati... ...
